Logo image of ZENV

ZENVIA INC - A (ZENV) Stock Fundamental Analysis

NASDAQ:ZENV - Nasdaq - KYG9889V1014 - Common Stock - Currency: USD

1.62  -0.08 (-4.71%)

Fundamental Rating

3

Taking everything into account, ZENV scores 3 out of 10 in our fundamental rating. ZENV was compared to 283 industry peers in the Software industry. ZENV has a bad profitability rating. Also its financial health evaluation is rather negative. ZENV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ZENV has reported negative net income.
ZENV had a positive operating cash flow in the past year.
ZENV had negative earnings in 4 of the past 5 years.
Of the past 5 years ZENV 4 years had a positive operating cash flow.
ZENV Yearly Net Income VS EBIT VS OCF VS FCFZENV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

ZENV has a Return On Assets of -2.78%. This is comparable to the rest of the industry: ZENV outperforms 57.60% of its industry peers.
ZENV has a Return On Equity (-5.79%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 1.10%, ZENV is doing good in the industry, outperforming 67.49% of the companies in the same industry.
Industry RankSector Rank
ROA -2.78%
ROE -5.79%
ROIC 1.1%
ROA(3y)-6.48%
ROA(5y)-3.73%
ROE(3y)-12.02%
ROE(5y)-8.14%
ROIC(3y)N/A
ROIC(5y)N/A
ZENV Yearly ROA, ROE, ROICZENV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

ZENV's Operating Margin of 1.70% is fine compared to the rest of the industry. ZENV outperforms 66.78% of its industry peers.
The Gross Margin of ZENV (38.88%) is worse than 74.56% of its industry peers.
ZENV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.7%
PM (TTM) N/A
GM 38.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y4.61%
ZENV Yearly Profit, Operating, Gross MarginsZENV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

ZENV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ZENV has been increased compared to 1 year ago.
The debt/assets ratio for ZENV has been reduced compared to a year ago.
ZENV Yearly Shares OutstandingZENV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M
ZENV Yearly Total Debt VS Total AssetsZENV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

ZENV has an Altman-Z score of 0.53. This is a bad value and indicates that ZENV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.53, ZENV is doing worse than 65.37% of the companies in the same industry.
The Debt to FCF ratio of ZENV is 9.53, which is on the high side as it means it would take ZENV, 9.53 years of fcf income to pay off all of its debts.
ZENV's Debt to FCF ratio of 9.53 is in line compared to the rest of the industry. ZENV outperforms 51.59% of its industry peers.
ZENV has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
ZENV has a Debt to Equity ratio (0.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 9.53
Altman-Z 0.53
ROIC/WACC0.05
WACC20.63%
ZENV Yearly LT Debt VS Equity VS FCFZENV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

ZENV has a Current Ratio of 0.50. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
ZENV has a Current ratio of 0.50. This is amonst the worse of the industry: ZENV underperforms 90.81% of its industry peers.
ZENV has a Quick Ratio of 0.50. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
ZENV has a worse Quick ratio (0.50) than 90.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.5
ZENV Yearly Current Assets VS Current LiabilitesZENV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

ZENV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.33%, which is quite impressive.
The Revenue has grown by 23.50% in the past year. This is a very strong growth!
ZENV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.92% yearly.
EPS 1Y (TTM)74.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%463.45%
Revenue 1Y (TTM)23.5%
Revenue growth 3Y23.41%
Revenue growth 5Y23.92%
Sales Q2Q%30.12%

3.2 Future

The Earnings Per Share is expected to grow by 35.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, ZENV will show a quite strong growth in Revenue. The Revenue will grow by 11.84% on average per year.
EPS Next Y-17.19%
EPS Next 2Y47.49%
EPS Next 3Y35.77%
EPS Next 5YN/A
Revenue Next Year23.18%
Revenue Next 2Y12.63%
Revenue Next 3Y11.84%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ZENV Yearly Revenue VS EstimatesZENV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ZENV Yearly EPS VS EstimatesZENV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZENV. In the last year negative earnings were reported.
ZENV is valuated quite expensively with a Price/Forward Earnings ratio of 58.00.
ZENV's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ZENV to the average of the S&P500 Index (20.42), we can say ZENV is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 58
ZENV Price Earnings VS Forward Price EarningsZENV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

ZENV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ZENV is cheaper than 97.88% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZENV is valued a bit cheaper than 67.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.6
EV/EBITDA 4.06
ZENV Per share dataZENV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ZENV's earnings are expected to grow with 35.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.49%
EPS Next 3Y35.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZENV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENVIA INC - A

NASDAQ:ZENV (5/6/2025, 4:30:02 PM)

1.62

-0.08 (-4.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)07-15 2025-07-15
Inst Owners7.42%
Inst Owner Change-0.14%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap84.03M
Analysts45.71
Price Target1.73 (6.79%)
Short Float %1.92%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)161.76%
Min EPS beat(2)-434.31%
Max EPS beat(2)757.84%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.7%
Min Revenue beat(2)1.77%
Max Revenue beat(2)11.63%
Revenue beat(4)4
Avg Revenue beat(4)79.86%
Min Revenue beat(4)0.78%
Max Revenue beat(4)305.25%
Revenue beat(8)6
Avg Revenue beat(8)111.42%
Revenue beat(12)8
Avg Revenue beat(12)70.4%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-92.75%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 58
P/S 0.5
P/FCF 37.6
P/OCF 6.26
P/B 0.54
P/tB N/A
EV/EBITDA 4.06
EPS(TTM)-0.21
EYN/A
EPS(NY)0.03
Fwd EY1.72%
FCF(TTM)0.04
FCFY2.66%
OCF(TTM)0.26
OCFY15.98%
SpS3.23
BVpS3.03
TBVpS-1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.78%
ROE -5.79%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.21%
ROICexgc N/A
OM 1.7%
PM (TTM) N/A
GM 38.88%
FCFM 1.33%
ROA(3y)-6.48%
ROA(5y)-3.73%
ROE(3y)-12.02%
ROE(5y)-8.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y4.61%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 9.53
Debt/EBITDA 0.44
Cap/Depr 67.29%
Cap/Sales 6.68%
Interest Coverage 0.85
Cash Conversion 68.94%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.5
Altman-Z 0.53
F-Score4
WACC20.63%
ROIC/WACC0.05
Cap/Depr(3y)58.95%
Cap/Depr(5y)58.15%
Cap/Sales(3y)5.54%
Cap/Sales(5y)4.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%463.45%
EPS Next Y-17.19%
EPS Next 2Y47.49%
EPS Next 3Y35.77%
EPS Next 5YN/A
Revenue 1Y (TTM)23.5%
Revenue growth 3Y23.41%
Revenue growth 5Y23.92%
Sales Q2Q%30.12%
Revenue Next Year23.18%
Revenue Next 2Y12.63%
Revenue Next 3Y11.84%
Revenue Next 5YN/A
EBIT growth 1Y119.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2379.67%
EBIT Next 3Y223.69%
EBIT Next 5YN/A
FCF growth 1Y-79.01%
FCF growth 3Y54.83%
FCF growth 5Y27.36%
OCF growth 1Y-24.31%
OCF growth 3Y52.2%
OCF growth 5Y32.63%